Reminder: This patent is currently under review and has not been authorized. There are many invention patents that have entered actual examination, but few have been granted final approval. The information searched on the website is as follows:
A drug for the treatment of rheumatoid arthritis
Under review - actual review
Application number: 201510308679.5 Application date: 2015-06-05
Abstract: The present invention discloses a medicine for treating rheumatoid arthritis, which is characterized in that: it is made from the following raw materials by weight: Guizhi 10-13 1-2 parts of Aconitum, 7-9 parts of Aconite, 1-3 parts of Asarum, 1-2 parts of Asarum, 4-6 parts of Astragalus, 2-4 parts of Morinda officinalis, 5-8 parts of Ephedra, 9-12 parts of dried ginger, 6-9 parts of licorice, 6-9 parts of kudzu root, 4-6 parts of green onion, 1-3 parts of gypsum, 9-13 parts of cordyceps, 8-11 parts of snow lotus, 7-10 parts of rhodiola rosea . The invention has the following advantages: the medicine for treating rheumatic joint bone disease has pure traditional Chinese medicine ingredients, no toxic side effects, no recurrence after cure, and can completely cure rheumatism, rheumatoid arthritis, bone hyperplasia, postpartum rheumatism and lumbar intervertebral disc herniation. , neck, shoulder, waist and leg pain and other common rheumatic diseases, the medicine of the present invention has a simple preparation method, is easy to process and produce, and has low cost, and the taking method is simple and does not need to be taken every day.
Applicant: Liu Bing Zhang Chaoheng
Address: Room 512, Building 7, No. 1, Zhujiang Road, Dongchangfu District, Liaocheng City, Shandong Province 252000
Invention ( Designer: Liu Bing